The Supreme Court has rejected a challenge from antiabortion doctors to limit access to mifepristone for medication abortion, allowing individuals to continue to obtain the pill nationwide.1The unanimous ruling reversed a lower court decision to restrict access to mifepristone, which is used in more than 60% of abortions in the United States. When accepting the case, the Supreme Court stated it would evaluate the rule changes in 2016 and 2021 that increased access to mifepristone and would not consider taking mifepristone off the market. The Supreme Court concluded that none of the plaintiffs’ theories were strong enough to establish a standing. “We are thrilled that a unanimous Supreme Court has rejected the ideologically driven lower court decisions on access to mifepristone, reversing an action that has already endangered too many people in need of healthcare," said the American Society for Reproductive Medicine. Supreme Court retains full access to key abortion medication mifepristone.

Source: Washington Post June 14, 2024 12:34 UTC